April 11, 2022
“Never Drinking Alcohol” Tied to ‘Significantly’ Higher MS Risk
- /
Not drinking alcohol significantly increases the risk of developing multiple sclerosis (MS), especially if a person also is a current or former…
MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.
April 11, 2022
New Bouts of Depression, Anxiety Linked to Pandemic, US Survey Finds
- /
- /
- /
- /
by Marisa Wexler MS | April 11, 2022 Many people with multiple sclerosis (MS) report new bouts of depression and anxiety as a result of…
April 11, 2022
$1M Invested in Study on Effects of Childhood-onset MS Over Time
- /
About CA$1.35 million ($1.07 million) has been invested in a project that seeks to understand the effects of multiple…
April 11, 2022
Poorer Sense of Smell Can Be Evident Even in Early Stages of MS, Study Says
- /
by Jose Marques Lopes PhD People with multiple sclerosis (MS) can indeed have a poorer-than-usual sense of smell, with problems possibly starting…
April 11, 2022
Smell Test Might Help Predict if MS Treatments Are Working
- /
- /
- /
A measure of the nose’s sensitivity to smell could be used to detect whether treatments for relapsing multiple sclerosis (MS) are…
April 6, 2022
Understanding Uhthoff’s Phenomenon: Overheating with MS
- /
When multiple sclerosis (MS) symptoms worsen from overheating, it’s called Uhthoff’s phenomenon. Learn more about prevention and treatment. Some people…
April 4, 2022
Learn to recognize and manage the possible symptoms of MS, which range from mild to severe.
- /
- /
More common symptoms Less common symptoms Secondary symptoms and the impact of disease Additional resources Click above links to read…
April 4, 2022
New Data for Genentech’s Ocrevus (Ocrelizumab) Show Benefit in Disability Progression and Cognitive Decline in Both Secondary Progressive and Primary Progressive Multiple Sclerosis
- /
- /
75% of patients with secondary progressive multiple sclerosis (SPMS) and primary progressive MS (PPMS) achieved no evidence of progression…
March 30, 2022
Latest updates for diagnosis and management of NMOSD
- /
In this enduring touchSATELLITE SYMPOSIUM (#ACTRIMS22), Prof. Sean Pittock, Dr Amy Kunchok, and Prof. Dean Wingerchuk share their insights…
March 29, 2022
About BAFIERTAM™ (monomethyl fumarate) treatment, for Multiple Sclerosis
- /
Banner Life Sciences Announces BAFIERTAM, a Novel Oral Fumarate Treatment for Relapsing Forms of Multiple Sclerosis, is available in the…
